Publicaciones científicas
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update
Elisa Ruiz-Arabi 1 , Julian Torre-Cisneros 2 , Victoria Aguilera 3 , Rodrigo Alonso 4 , Marina Berenguer 3 , Oriol Bestard 5 , Marta Bodro 6 , Sara Cantisán 7 , Jordi Carratalà 8 , Juan José Castón 7 , Elisa Cordero 9 , Carme Facundo 10 , María Carmen Fariñas 11 , Mirian Fernández-Alonso 12 , Mario Fernández-Ruiz 13 , Jesús Fortún 14 , Maria Dolores García-Cosío 15 , Sabina Herrera 16 , David Iturbe-Fernández 17 , Oscar Len 18 , Francisco López-Medrano 13 , María Ovidia López-Oliva 19 , Ibai Los-Arcos 20 , María Ángeles Marcos 21 , Pilar Martín-Dávila 14 , Víctor Monforte 22 , Patricia Muñoz 23 , David Navarro 24 , Aurora Páez-Vega 25 , Ana Belén Pérez 26 , Natalia Redondo 13 , Regino Rodríguez Álvarez 27 , Alberto Rodríguez-Benot 28 , Isabel Rodríguez-Goncer 13 , Rafael San-Juan 13 , Javier Sánchez-Céspedes 29 , Maricela Valerio 23 , José Manuel Vaquero 30 , Diego Viasus 31 , Elisa Vidal 7 , José María Aguado 32
Abstract
Cytomegalovirus (CMV) infection remains a significant challenge in solid organ transplantation (SOT). The last international consensus guidelines on the management of CMV in SOT were published in 2018, highlighting the need for revision to incorporate recent advances, notably in cell-mediated immunity monitoring, which could alter the current standard of care.
A working group including members from the Group for the Study of Infection in Transplantation and the Immunocompromised Host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Transplantation (SET), developed consensus-based recommendations for managing CMV infection in SOT recipients.
Recommendations were classified based on evidence strength and quality using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. The final recommendations were endorsed through a consensus meeting and approved by the expert panel.
CITA DEL ARTÍCULO Transplant Rev (Orlando). 2024 Aug 5;38(4):100875. doi: 10.1016/j.trre.2024.100875
Nuestros autores
